Skip to content

A Study of Combined Microfocused Ultrasound and Picosecond 755-nm Alexandrite Laser for The Treatment of Enlarged Facial Pores

A Study of Combined Microfocused Ultrasound and Picosecond 755-nm Alexandrite Laser for The Treatment of Enlarged Facial Pores

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220726003
Enrollment
30
Registered
2022-07-26
Start date
2021-11-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enlarged facial pores Rejuvenation

Interventions

microfocused ultrasound with visualization (MFU-V) monotherapy versus MFU-V combined with picosecond 755-nm alexandrite laser with diffractive lens array
Experimental Procedure/Surgery
one session of microfocused ultrasound with visualization combined with picosecond 755-nm alexandrite laser

Sponsors

Dermatology department, Faculty of Medicine, Ramathibodi hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 18 years or more who had enlarged skin pores evenly on both cheeks.

Exclusion criteria

Exclusion criteria: (i) severe medical conditions, (ii) other skin diseases on the face, (iii) immunocompromised status, (iv) history of skin cancer or keloids, (v) history of adverse reactions to anesthetics or injectable fillers, (vi) history of laser therapy or other facial procedures on the cheek within 3 months prior to the study, (vii) history of treatment with systemic vitamin A and its derivatives within 3 months prior to the study, (ix) metal implants at the area of study, (x) pregnancy or lactation, and/or (xi) dental root canal disease.

Design outcomes

Primary

MeasureTime frame
Pore volume baseline, 1, 2, 4, and 6 months Antera 3D

Secondary

MeasureTime frame
Pore severity baseline, 1, 2, 4, and 6 months A blinded dermatologist

Countries

Thailand

Contacts

Public ContactVasanop Vachiramon

Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University

vasanop@gmail.com0946369165

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026